ENDRA Life Sciences Reports Second Quarter 2024 Financial Results and Provides a Business Update

Stock Information for ENDRA Life Sciences Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About ENDRA Life Sciences Inc.

ENDRA Life Sciences Activates TAEUS System to Initiate Clinical Study at LMU University Hospital in Germany
ENDRA Life Sciences Granted Extension to Regain Compliance with Nasdaq Continued Listing Requirements
ENDRA Life Sciences Announces Reverse Stock Split
ENDRA Life Sciences Reschedules Second Quarter Conference Call to August 22, 2024
ENDRA Life Sciences Announces Leadership Changes
ENDRA Life Sciences to Report Second Quarter 2024 Financial Results on August 14
ENDRA Life Sciences Announces Pricing of $8.0 Million Public Offering
ENDRA Provides Update Following In-person Meeting with FDA

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.